{"id":"NCT01196091","sponsor":"Eli Lilly and Company","briefTitle":"A Study of LY2127399 in Participants With Systemic Lupus Erythematosus","officialTitle":"A Phase 3, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Participants With Systemic Lupus Erythematosus (SLE)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-12","primaryCompletion":"2014-07","completion":"2015-06","firstPosted":"2010-09-08","resultsPosted":"2018-06-12","lastUpdate":"2018-06-12"},"enrollment":1164,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Systemic Lupus Erythematosus","Connective Tissue Disease","Autoimmune Disease"],"interventions":[{"type":"DRUG","name":"LY2127399","otherNames":[]},{"type":"DRUG","name":"Placebo every 2 weeks","otherNames":[]},{"type":"DRUG","name":"Placebo every 4 weeks","otherNames":[]},{"type":"DRUG","name":"Standard of Care","otherNames":["Non-steroidal anti-inflammatory drug","Corticosteroids","Antimalarials (used for SLE)","Immunosuppressants"]}],"arms":[{"label":"LY2127399 every 2 weeks","type":"EXPERIMENTAL"},{"label":"LY2127399 every 4 wks","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this SLE study is to evaluate the efficacy, safety and tolerability of two different doses of LY2127399 administered in participants with active SLE.","primaryOutcome":{"measure":"Percentage of Participants Achieving an SLE Responder Index Response at Week 52","timeFrame":"52 weeks","effectByArm":[{"arm":"LY2127399 Every 2 Weeks","deltaMin":31.8,"sd":null},{"arm":"LY2127399 Every 4 Wks","deltaMin":35.2,"sd":null},{"arm":"Placebo","deltaMin":29.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":15},"locations":{"siteCount":192,"countries":["United States","Argentina","Austria","Belarus","Bulgaria","Canada","Chile","Colombia","Croatia","Egypt","Germany","Guatemala","Italy","Japan","North Macedonia","Peru","Philippines","Poland","Puerto Rico","Singapore","South Korea","Thailand","Ukraine"]},"refs":{"pmids":["38676311","35947992","31790472","29045736","27723281","27220348","26338095"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":42,"n":386},"commonTop":["Urinary tract infection","Upper respiratory tract infection","Headache","Nasopharyngitis","Diarrhoea"]}}